Given that NF-κB pathway plays essential roles in activating survival genes for cancer cells as well as inflammatory response in immune cells [53, 54], we speculate that ELF3 may function as an important modulator of NF-κB pathway in LUAD. The gene discussed is NFKB1; the disease is cancer.